Endonovo Therapeutics, Inc. SEC filings ENDV

Endonovo Therapeutics, Inc. has 502 filings in SEC EDGAR's recent list, going back to Sep 22, 2011. Its latest annual report, Form 10-K, was filed on Apr 17, 2023 for the period ended Dec 31, 2022. The latest quarterly report (Form 10-Q) was filed on Dec 29, 2023, covering the quarter ended Sep 30, 2023. The most recent current report (Form 8-K) was filed on Jan 3, 2024 (material agreement). The company's fiscal year ends on December 31.

Endonovo Therapeutics, Inc. SEC filings
Form Description Filed Period
10-K Annual report Apr 17, 2023 Dec 31, 2022
10-K Annual report Apr 14, 2022 Dec 31, 2021
10-K Annual report Apr 13, 2021 Dec 31, 2020
10-K Annual report May 4, 2020 Dec 31, 2019
10-K Annual report Apr 15, 2019 Dec 31, 2018
10-K Annual report Apr 6, 2018 Dec 31, 2017
10-K Annual report Apr 17, 2017 Dec 31, 2016
10-K/A Amended annual report May 17, 2016 Dec 31, 2015
10-K Annual report Apr 5, 2016 Dec 31, 2015
10-K/A Amended annual report Jun 15, 2015 Dec 31, 2014
10-K Annual report Apr 3, 2015 Dec 31, 2014
10-K Annual report Apr 15, 2014 Dec 31, 2013
10-K/A Amended annual report May 3, 2013 Dec 31, 2012
10-K Annual report Apr 16, 2013 Dec 31, 2012
10-K Annual report Apr 16, 2013 Dec 31, 2012
10-K Annual report Apr 13, 2012 Dec 31, 2011

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
ENDV (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Woodland Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1528172
Former names
Hanover Portfolio Acquisitions, Inc. (until Jan 24, 2014)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.